Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Friedman said FDA is considering release of stability guidance

This article was originally published in The Gold Sheet

Executive Summary

CDER's Friedman reported at the June 23 meeting that any type of stability guideline issued by FDA will be "small scale," designed to complement the ICH guideline on stability testing. Friedman noted that FDA withdrew its stability guidance when the ICH guidance was issued in 1997. Other guidances due out soon, reported Friedman, include a new guidance on process validation and a guidance on parametric releas

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000105

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel